Zuvius Launches Cytraz In 100mg, 500mg And 1gm

Zuvius Launches Cytraz in 100mg, 500mg, and 1gm, used in the treatment of cancers of white blood cells such as acute myeloied leukemia (AML) and non-Hodgkin Lymphoma.

Also read : Zuvius Launches Zinotecan In 100mg, And 40 Mg

CYTRAZ (CYTARABINE INJECTION BP)

COMPOISTION

Each ml contains:

Cytarabine BP……………………….100mg

Water for injection BP ……………….q.s.

Indications :

Cytarabine is useful in various neoplastic disorders including acute lymphocytic leukemia (ALL), acute myelogenous leukemia (AML), acute nonlymphocytic leukemia (ANILL), chronic myeloid leukemia, acute promyelocytic leukemia, meningeal neoplasms, and carcinomatous meningitis. Cytarabine may be effective in the treatment of Non-Hodgkin’s Lymphoma, malignant pleural effusions, multiple myeloma, myelodysplastic syndrome and Leukoencephalopathy. Other disease state in which cytarabine has been used include herpes virus infections and psorials.

Packing :

100 mg/1mL Single-Use Vial

500 mg/5mL Single-Use Vial

1000 mg/10mL Single-Use Vial

To know more : Cytarabine

Leave a reply